EUVIMED · CrossrefZeitschrift
Annals of Pancreatic Cancer
ISSN 2616-2741 · AME Publishing Company
Neueste Artikel
Prognostic and predictive biomarkers in pancreatic cancer: the role of circulating tumor cells and cell-free nucleic acids—a narrative review
Post-translational histone modifications in pancreatic neuroendocrine tumors: a narrative review of a new frontier in epigenomic research
The FIBROPANC paradox
Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review
Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma
Discordant microsatellite instability assessment in pancreatic adenocarcinoma: a case report
Adaptive Precision Oncology for pancreatic ductal adenocarcinoma: a review
Double primary biliary malignancy: synchronous gallbladder carcinoma and extrahepatic cholangiocarcinoma in a Whipple specimen—a case report and literature review
Engineered exosomes silence oncogenic KRASG12D and awaken immunity in pancreatic cancer
Precision immunotherapy in metastatic pancreatic cancer: OPTIMIZE-1 biomarker-driven patient stratification for future studies
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study
Remodeling of tumour microenvironment of pancreatic cancer: can agonistic anti-CD40 antibodies give a new direction?
ATP1B1::PRKACA fusion-defined intraductal oncocytic papillary neoplasm of the pancreas: a case report
Incremental innovation in endoscopic ultrasound-guided biopsy: does the tip make the difference?
18F-prostate specific membrane antigen positron emission tomography/computed tomography for pancreatic ductal adenocarcinoma: not specific enough
Targeting drug efflux in pancreatic cancer: what the PANTAX trial teaches us about resisting resistance
Liquid biopsy and biomarkers in pancreatic ductal adenocarcinoma: from concept to clinical translation—a narrative review
Can preoperative radiotherapy reduce the risk of postoperative pancreatic fistula after pancreatoduodenectomy?
Comparing neoadjuvant regimens in resectable and borderline resectable pancreatic cancer: lessons from PREOPANC-2
Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1
CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves
The evolving neoadjuvant landscape in pancreatic cancer: biology often overrides anatomy in achieving margin-negative resection
PASS-01: the final step on the journey towards the optimal chemotherapy regimen for metastatic pancreatic adenocarcinoma?
Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial
Perioperative therapy to control hepatic micrometastases in pancreatic ductal adenocarcinoma: an appraisal of the TOSPAC-02 study
Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma—two case reports
Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review
Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon
Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival
EUVIMED